+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel



Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel



Drug Safety 34(7): 587-593



Computerized physician order entry systems are known to improve patient safety in acute-care hospitals. However, as clinicians frequently override drug interaction and allergy alerts, their value in ambulatory care remains uncertain. The purpose of the study was to examine whether ambulatory care clinicians were more likely to accept drug-drug interaction alerts that an expert panel judged to be of high clinical value. We convened an expert panel to examine drug-drug interaction alerts generated by 2872 clinicians in Massachusetts, Pennsylvania and New Jersey who used a common electronic prescribing system between 1 January 2006 and 30 September 2006. We selected 120 representative drug interaction alerts from the most commonly encountered class-class interactions. The expert panel rated each alert based on the following categories: (i) strength of the scientific evidence; (ii) probability that the interaction would result in an adverse drug event (ADE); (iii) severity of typical and most serious ADEs; (iv) the likelihood that a clinician could act on the information; and (v) the overall value of the alert to the average primary care clinician. We then used multivariate regression techniques to examine the relationship between the alert acceptance rate and the expert panel's mean rating of each category. The decision of clinicians to accept drug interaction alerts increased (relative to a baseline alert acceptance rate of 8.8%) by 2.7% (95% CI 0.4, 5.1) for interactions that panelists judged would result in an ADE, by 2.3% (95% CI 0.9, 3.7) when primary care providers (PCPs) lacked prior knowledge about the information presented in the alert, and by 3.3% (95% CI 0.9, 5.8) when the PCP could readily act on the information provided in the alert. The value of electronic drug interaction alerts is influenced heavily by clinicians' judgements about the clinical value of the alert. Expert judgement should be taken into account when developing electronic decision support.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052927550

Download citation: RISBibTeXText

PMID: 21663334

DOI: 10.2165/11589360-000000000-00000


Related references

Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream of CPOE alerts. Journal of the American Medical Informatics Association 18 Suppl 1: I45-I50, 2012

Variation in high-priority drug-drug interaction alerts across institutions and electronic health records. Journal of the American Medical Informatics Association 24(2): 331-338, 2016

Improving acceptance of computerized prescribing alerts in ambulatory care. Journal of the American Medical Informatics Association 13(1): 5-11, 2005

Evaluation of accuracy of drug interaction alerts triggered by two electronic medical record systems in primary healthcare. Health Informatics Journal 13(3): 163-177, 2007

Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior?. Journal of Oncology Pharmacy Practice 20(3): 163-171, 2014

Acceptance of drug-drug interaction alerts and alert system design. British Journal of Clinical Pharmacology 70(4): 619-620, 2011

Clinicians' assessments of electronic medication safety alerts in ambulatory care. Archives of Internal Medicine 169(17): 1627-1632, 2009

Effect of modifying dose alerts in an electronic health record on frequency of alerts. American Journal of Health-System Pharmacy 76(Suppl._1): S1-S8, 2019

Non-interruptive drug-lab alerts in ambulatory care. AMIA ... Annual Symposium Proceedings. AMIA Symposium 2008: 1038, 2008

Presenting multiple drug alerts in an ambulatory electronic prescribing system: a usability study of novel prototypes. Applied Clinical Informatics 5(2): 334-348, 2015

Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department. Annals of Emergency Medicine 67(2): 240-248.E3, 2016

Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record. Journal of General Internal Medicine 33(11): 1868-1876, 2018

Utility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity. Clinical Journal of the American Society of Nephrology 2018, 2018

Successful strategy to improve the specificity of electronic statin-drug interaction alerts. European Journal of Clinical Pharmacology 65(11): 1149-1157, 2009

Core drug-drug interaction alerts for inclusion in pediatric electronic health records with computerized prescriber order entry. Journal of Patient Safety 10(1): 59-63, 2014